These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 3244627

  • 1. Mean residence time concepts for pharmacokinetic systems with nonlinear drug elimination described by the Michaelis-Menten equation.
    Cheng HY, Jusko WJ.
    Pharm Res; 1988 Mar; 5(3):156-64. PubMed ID: 3244627
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Application of moment analysis to nonlinear drug disposition described by the Michaelis-Menten equation.
    Chow AT, Jusko WJ.
    Pharm Res; 1987 Feb; 4(1):59-61. PubMed ID: 3508531
    [Abstract] [Full Text] [Related]

  • 4. Mean residence times and distribution volumes for drugs undergoing linear reversible metabolism and tissue distribution and linear or nonlinear elimination from the central compartments.
    Cheng HY, Jusko WJ.
    Pharm Res; 1991 Apr; 8(4):508-11. PubMed ID: 1871048
    [Abstract] [Full Text] [Related]

  • 5. Volume of distribution at steady state for a linear pharmacokinetic system with peripheral elimination.
    Berezhkovskiy LM.
    J Pharm Sci; 2004 Jun; 93(6):1628-40. PubMed ID: 15124219
    [Abstract] [Full Text] [Related]

  • 6. Relationships between steady-state and single-dose plasma drug concentrations for pharmacokinetic systems with nonlinear elimination.
    Cheng HY, Jusko WJ.
    Biopharm Drug Dispos; 1989 Jun; 10(5):513-28. PubMed ID: 2804255
    [Abstract] [Full Text] [Related]

  • 7. Michaelis-Menten metabolite formation kinetics: equations relating area under the curve and metabolite recovery to the administered dose.
    Chow AT, Jusko WJ.
    J Pharm Sci; 1990 Oct; 79(10):902-6. PubMed ID: 2280360
    [Abstract] [Full Text] [Related]

  • 8. Simulation for population analysis of Michaelis-Menten elimination kinetics.
    Hashimoto Y, Koue T, Otsuki Y, Yasuhara M, Hori R, Inui K.
    J Pharmacokinet Biopharm; 1995 Apr; 23(2):205-16. PubMed ID: 8719237
    [Abstract] [Full Text] [Related]

  • 9. Mean residence time of drugs administered non-instantaneously and undergoing linear tissue distribution and reversible metabolism and linear or non-linear elimination from the central compartment.
    Cheng H.
    Biopharm Drug Dispos; 1995 May; 16(4):259-67. PubMed ID: 7548775
    [Abstract] [Full Text] [Related]

  • 10. Determination of volume of distribution at steady state with complete consideration of the kinetics of protein and tissue binding in linear pharmacokinetics.
    Berezhkovskiy LM.
    J Pharm Sci; 2004 Feb; 93(2):364-74. PubMed ID: 14705193
    [Abstract] [Full Text] [Related]

  • 11. A derivation of mean residence time.
    Becker R.
    Eur J Drug Metab Pharmacokinet; 1991 Feb; Spec No 3():15-6. PubMed ID: 1820869
    [Abstract] [Full Text] [Related]

  • 12. Volumes of distribution and mean residence time of drugs with linear tissue distribution and binding and nonlinear protein binding.
    Cheng H, Gillespie WR.
    J Pharmacokinet Biopharm; 1996 Aug; 24(4):389-402. PubMed ID: 9044167
    [Abstract] [Full Text] [Related]

  • 13. Drug redistribution and mean transit time concepts for nonlinear pharmacokinetic systems.
    Cheng HY, Jusko WJ.
    Biopharm Drug Dispos; 1991 Aug; 12(1):73-9. PubMed ID: 2039813
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Use of mean residence time to determine the magnitude of difference between rate constants and to calculate tmax in the Bateman equation.
    Volosov A, Bialer M.
    Biopharm Drug Dispos; 1999 Jan; 20(1):3-9. PubMed ID: 10086832
    [Abstract] [Full Text] [Related]

  • 16. The relationships between half-life (t1/2) and mean residence time (MRT) in the two-compartment open body model.
    Sobol E, Bialer M.
    Biopharm Drug Dispos; 2004 May; 25(4):157-62. PubMed ID: 15108218
    [Abstract] [Full Text] [Related]

  • 17. Dose-dependent pharmacokinetics of mezlocillin in rats.
    Jungbluth GL, Jusko WJ.
    Antimicrob Agents Chemother; 1989 Jun; 33(6):839-43. PubMed ID: 2764534
    [Abstract] [Full Text] [Related]

  • 18. On the accuracy of estimation of basic pharmacokinetic parameters by the traditional noncompartmental equations and the prediction of the steady-state volume of distribution in obese patients based upon data derived from normal subjects.
    Berezhkovskiy LM.
    J Pharm Sci; 2011 Jun; 100(6):2482-97. PubMed ID: 21254063
    [Abstract] [Full Text] [Related]

  • 19. Definitions and applications of mean transit and residence times in reference to the two-compartment mammillary plasma clearance model.
    Kong AN, Jusko WJ.
    J Pharm Sci; 1988 Feb; 77(2):157-65. PubMed ID: 3361431
    [Abstract] [Full Text] [Related]

  • 20. Types of mean residence times.
    Wagner JG.
    Biopharm Drug Dispos; 1988 Feb; 9(1):41-57. PubMed ID: 3342284
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.